Rank | Gene Set | Z-score |
---|---|---|
1 | iron ion import (GO:0097286) | 5.13103590 |
2 | cellular response to ethanol (GO:0071361) | 4.77447447 |
3 | interkinetic nuclear migration (GO:0022027) | 4.54149309 |
4 | nuclear pore complex assembly (GO:0051292) | 4.51349512 |
5 | activated T cell proliferation (GO:0050798) | 4.38205546 |
6 | histone H3-K4 trimethylation (GO:0080182) | 4.11631903 |
7 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.10579124 |
8 | pre-miRNA processing (GO:0031054) | 4.10063254 |
9 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.01480188 |
10 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.00136661 |
11 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.00136661 |
12 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.00136661 |
13 | negative regulation of fatty acid transport (GO:2000192) | 3.93895932 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87241564 |
15 | lipid translocation (GO:0034204) | 3.85562363 |
16 | phospholipid translocation (GO:0045332) | 3.85562363 |
17 | mature B cell differentiation (GO:0002335) | 3.82689483 |
18 | nuclear pore organization (GO:0006999) | 3.67715594 |
19 | negative regulation of DNA repair (GO:0045738) | 3.63880945 |
20 | Golgi to endosome transport (GO:0006895) | 3.63512698 |
21 | import into cell (GO:0098657) | 3.60354538 |
22 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.56410453 |
23 | histone H3-K36 demethylation (GO:0070544) | 3.50551487 |
24 | cellular response to zinc ion (GO:0071294) | 3.48981650 |
25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.44548751 |
26 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.42494858 |
27 | germ cell migration (GO:0008354) | 3.42426839 |
28 | establishment of protein localization to Golgi (GO:0072600) | 3.37534074 |
29 | protein targeting to Golgi (GO:0000042) | 3.36059112 |
30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33150821 |
31 | regulation of pigment cell differentiation (GO:0050932) | 3.31229925 |
32 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.29479993 |
33 | I-kappaB phosphorylation (GO:0007252) | 3.28018242 |
34 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 3.25097172 |
35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.24033326 |
36 | B cell receptor signaling pathway (GO:0050853) | 3.23867305 |
37 | nucleus localization (GO:0051647) | 3.23577874 |
38 | negative regulation of B cell proliferation (GO:0030889) | 3.22739171 |
39 | pore complex assembly (GO:0046931) | 3.22655683 |
40 | regulation of ARF protein signal transduction (GO:0032012) | 3.22405789 |
41 | positive regulation of developmental pigmentation (GO:0048087) | 3.21979483 |
42 | determination of adult lifespan (GO:0008340) | 3.20395922 |
43 | peptidyl-lysine trimethylation (GO:0018023) | 3.18863949 |
44 | mitochondrion distribution (GO:0048311) | 3.17122465 |
45 | glomerular visceral epithelial cell development (GO:0072015) | 3.15354442 |
46 | regulation of establishment of cell polarity (GO:2000114) | 3.13389081 |
47 | regulation of protein polyubiquitination (GO:1902914) | 3.13130864 |
48 | entry into other organism involved in symbiotic interaction (GO:0051828) | 3.11579534 |
49 | movement in host environment (GO:0052126) | 3.11579534 |
50 | entry into host cell (GO:0030260) | 3.11579534 |
51 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 3.11579534 |
52 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 3.11579534 |
53 | entry into host (GO:0044409) | 3.11579534 |
54 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09835072 |
55 | negative regulation of cell killing (GO:0031342) | 3.09835072 |
56 | mitotic sister chromatid cohesion (GO:0007064) | 3.02243678 |
57 | regulation of fibroblast apoptotic process (GO:2000269) | 3.01225415 |
58 | locomotory exploration behavior (GO:0035641) | 2.98467868 |
59 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.96191048 |
60 | histone demethylation (GO:0016577) | 2.94941195 |
61 | nerve growth factor signaling pathway (GO:0038180) | 2.92752363 |
62 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.85524620 |
63 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.84595085 |
64 | protein K48-linked deubiquitination (GO:0071108) | 2.83540914 |
65 | regulation of RNA export from nucleus (GO:0046831) | 2.81891917 |
66 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.80423173 |
67 | peptidyl-lysine methylation (GO:0018022) | 2.79884426 |
68 | histone H3-K9 demethylation (GO:0033169) | 2.78903728 |
69 | negative regulation of histone methylation (GO:0031061) | 2.77911226 |
70 | definitive hemopoiesis (GO:0060216) | 2.76088964 |
71 | regulation of B cell apoptotic process (GO:0002902) | 2.74543165 |
72 | histone H3-K4 methylation (GO:0051568) | 2.73559407 |
73 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.71588493 |
74 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71415053 |
75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71415053 |
76 | modulation by symbiont of host immune response (GO:0052553) | 2.71415053 |
77 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71415053 |
78 | modulation by symbiont of host defense response (GO:0052031) | 2.71415053 |
79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71415053 |
80 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.70813979 |
81 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.70147224 |
82 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.70040866 |
83 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.69554964 |
84 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.69554964 |
85 | myelin maintenance (GO:0043217) | 2.69406585 |
86 | phospholipid homeostasis (GO:0055091) | 2.69377470 |
87 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.68558303 |
88 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.67638192 |
89 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.67332304 |
90 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.67011406 |
91 | histone mRNA catabolic process (GO:0071044) | 2.66254946 |
92 | positive thymic T cell selection (GO:0045059) | 2.66040877 |
93 | NLS-bearing protein import into nucleus (GO:0006607) | 2.65689596 |
94 | regulation of histone H3-K9 methylation (GO:0051570) | 2.63014847 |
95 | peptidyl-threonine phosphorylation (GO:0018107) | 2.62006600 |
96 | negative regulation of granulocyte differentiation (GO:0030853) | 2.60543784 |
97 | glomerular epithelial cell development (GO:0072310) | 2.60258130 |
98 | B cell proliferation (GO:0042100) | 2.59422089 |
99 | B cell homeostasis (GO:0001782) | 2.58955809 |
100 | T cell proliferation (GO:0042098) | 2.58887565 |
101 | peptidyl-lysine dimethylation (GO:0018027) | 2.56871139 |
102 | regulation of DNA endoreduplication (GO:0032875) | 2.56257757 |
103 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.56243066 |
104 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56145468 |
105 | regulation of B cell proliferation (GO:0030888) | 2.55098186 |
106 | peptidyl-threonine modification (GO:0018210) | 2.54577760 |
107 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.53650261 |
108 | phospholipid dephosphorylation (GO:0046839) | 2.53356684 |
109 | regulation of membrane lipid distribution (GO:0097035) | 2.52753529 |
110 | viral entry into host cell (GO:0046718) | 2.52645105 |
111 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.52444545 |
112 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52114775 |
113 | response to lipoprotein particle (GO:0055094) | 2.51399240 |
114 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51055124 |
115 | establishment of nucleus localization (GO:0040023) | 2.50963870 |
116 | positive regulation of B cell differentiation (GO:0045579) | 2.50606342 |
117 | snRNA transcription (GO:0009301) | 2.49072282 |
118 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48853844 |
119 | embryonic process involved in female pregnancy (GO:0060136) | 2.47648694 |
120 | histone lysine demethylation (GO:0070076) | 2.47631706 |
121 | protein targeting to lysosome (GO:0006622) | 2.47506667 |
122 | establishment of protein localization to vacuole (GO:0072666) | 2.47506667 |
123 | protein targeting to vacuole (GO:0006623) | 2.47506667 |
124 | regulation of histone H3-K27 methylation (GO:0061085) | 2.46968324 |
125 | early endosome to late endosome transport (GO:0045022) | 2.45907555 |
126 | protein localization to endosome (GO:0036010) | 2.45064254 |
127 | carnitine shuttle (GO:0006853) | 2.44622250 |
128 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.44575545 |
129 | positive regulation of muscle hypertrophy (GO:0014742) | 2.44575545 |
130 | COPII vesicle coating (GO:0048208) | 2.44531416 |
131 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.43771206 |
132 | protein dealkylation (GO:0008214) | 2.43098886 |
133 | protein demethylation (GO:0006482) | 2.43098886 |
134 | lymphocyte proliferation (GO:0046651) | 2.41278333 |
135 | pinocytosis (GO:0006907) | 2.39960645 |
136 | Golgi to plasma membrane transport (GO:0006893) | 2.39043204 |
137 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.38766173 |
138 | dosage compensation (GO:0007549) | 2.38730887 |
139 | mononuclear cell proliferation (GO:0032943) | 2.38436362 |
140 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.36825629 |
141 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.36349592 |
142 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.34938986 |
143 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.34938986 |
144 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.34900726 |
145 | positive T cell selection (GO:0043368) | 2.34074376 |
146 | positive regulation of interleukin-2 production (GO:0032743) | 2.33108234 |
147 | positive regulation of macrophage cytokine production (GO:0060907) | 2.33099804 |
148 | intracellular lipid transport (GO:0032365) | 2.32835671 |
149 | regulation of Rac protein signal transduction (GO:0035020) | 2.32753399 |
150 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.31762587 |
151 | Golgi organization (GO:0007030) | 2.29364217 |
152 | histone lysine methylation (GO:0034968) | 2.29227413 |
153 | regulation of germinal center formation (GO:0002634) | 2.28649177 |
154 | corticosteroid receptor signaling pathway (GO:0031958) | 2.28072209 |
155 | nucleus organization (GO:0006997) | 2.26755120 |
156 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.26624618 |
157 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.26288818 |
158 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.25984680 |
159 | Rap protein signal transduction (GO:0032486) | 2.24566630 |
160 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.24380670 |
161 | microtubule anchoring (GO:0034453) | 2.24238524 |
162 | phosphatidylinositol phosphorylation (GO:0046854) | 2.23832771 |
163 | oligosaccharide catabolic process (GO:0009313) | 2.20153654 |
164 | genitalia morphogenesis (GO:0035112) | 2.19827476 |
165 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.19470099 |
166 | macroautophagy (GO:0016236) | 2.19083961 |
167 | fibroblast migration (GO:0010761) | 2.15210461 |
168 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.14357027 |
169 | labyrinthine layer development (GO:0060711) | 2.14111902 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.72157810 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.47215108 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.33775965 |
4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.06271434 |
5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.86840903 |
6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.84916013 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55810276 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44472037 |
9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19243197 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18436952 |
11 | TP53_16413492_ChIP-PET_HCT116_Human | 2.07425498 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05705728 |
13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.97478791 |
14 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.93144234 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84560251 |
16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83923572 |
17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80348888 |
18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75933433 |
19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75856670 |
20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73573183 |
21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70850733 |
22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69789944 |
23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66821809 |
24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65322756 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64348212 |
26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63987539 |
27 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.61140137 |
28 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.56857457 |
29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56359064 |
30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49851327 |
31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49793923 |
32 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.48081672 |
33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43559149 |
34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42867471 |
35 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40968327 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40568965 |
37 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40323325 |
38 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.39728677 |
39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38986144 |
40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38473642 |
41 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38333542 |
42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37754517 |
43 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.34185981 |
44 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34185981 |
45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32978168 |
46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32909911 |
47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31813196 |
48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31683313 |
49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31445756 |
50 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.30912971 |
51 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.30402434 |
52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30357477 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29821284 |
54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.28710905 |
55 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.28688852 |
56 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26868337 |
57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26318051 |
58 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.25198145 |
59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24946376 |
60 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.23673455 |
61 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.23058418 |
62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22746794 |
63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21747697 |
64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20416053 |
65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20225225 |
66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20125659 |
67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18647991 |
68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17723926 |
69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17719048 |
70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17704832 |
71 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.17423772 |
72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17215041 |
73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16128085 |
74 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.14241707 |
75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14175176 |
76 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.13531035 |
77 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13433517 |
78 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13143812 |
79 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12522985 |
80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12375580 |
81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10444860 |
82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09297958 |
83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09163247 |
84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08975442 |
85 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08022235 |
86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07815016 |
87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07696348 |
88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06919079 |
89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04719595 |
90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04455038 |
91 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03253028 |
92 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02370805 |
93 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02362463 |
94 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02269448 |
95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02258115 |
96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01922989 |
97 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01261719 |
98 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.00355690 |
99 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00231712 |
100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99381338 |
101 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98978492 |
102 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98337506 |
103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98044644 |
104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97909467 |
105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96014876 |
106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96014876 |
107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95951299 |
108 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95837983 |
109 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95775112 |
110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95001972 |
111 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94588604 |
112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93740563 |
113 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.92459947 |
114 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91592412 |
115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91545667 |
116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91133869 |
117 | * AR_19668381_ChIP-Seq_PC3_Human | 0.90759717 |
118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88523582 |
119 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.87376521 |
120 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87135463 |
121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87121198 |
122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86950787 |
123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86757035 |
124 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86401275 |
125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86353678 |
126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84667823 |
127 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84534717 |
128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84506898 |
129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84506898 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 7.90710992 |
2 | MP0008057_abnormal_DNA_replication | 3.96420601 |
3 | MP0002166_altered_tumor_susceptibility | 3.65201722 |
4 | MP0003787_abnormal_imprinting | 3.42478720 |
5 | MP0003300_gastrointestinal_ulcer | 3.31220758 |
6 | MP0005076_abnormal_cell_differentiation | 2.82482368 |
7 | MP0002006_tumorigenesis | 2.70359590 |
8 | MP0010234_abnormal_vibrissa_follicle | 2.69432506 |
9 | MP0002009_preneoplasia | 2.53313051 |
10 | MP0003183_abnormal_peptide_metabolism | 2.52154640 |
11 | MP0003172_abnormal_lysosome_physiology | 2.18796852 |
12 | MP0010352_gastrointestinal_tract_polyps | 2.15773310 |
13 | MP0003045_fibrosis | 2.14851852 |
14 | MP0010307_abnormal_tumor_latency | 2.13533296 |
15 | MP0001800_abnormal_humoral_immune | 2.12476763 |
16 | MP0005451_abnormal_body_composition | 2.07286371 |
17 | MP0002877_abnormal_melanocyte_morpholog | 2.05672163 |
18 | MP0001835_abnormal_antigen_presentation | 1.96139576 |
19 | MP0005409_darkened_coat_color | 1.92949739 |
20 | MP0003091_abnormal_cell_migration | 1.92539812 |
21 | MP0002254_reproductive_system_inflammat | 1.85241692 |
22 | MP0003303_peritoneal_inflammation | 1.83455022 |
23 | MP0005174_abnormal_tail_pigmentation | 1.75043582 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.74541540 |
25 | MP0001790_abnormal_immune_system | 1.73682135 |
26 | MP0005387_immune_system_phenotype | 1.73682135 |
27 | MP0000015_abnormal_ear_pigmentation | 1.73238525 |
28 | MP0003950_abnormal_plasma_membrane | 1.68009944 |
29 | MP0008961_abnormal_basal_metabolism | 1.64107004 |
30 | MP0002928_abnormal_bile_duct | 1.61867391 |
31 | MP0009780_abnormal_chondrocyte_physiolo | 1.61478508 |
32 | MP0002452_abnormal_antigen_presenting | 1.55911379 |
33 | MP0004043_abnormal_pH_regulation | 1.54154869 |
34 | MP0005647_abnormal_sex_gland | 1.52376189 |
35 | MP0003705_abnormal_hypodermis_morpholog | 1.51638404 |
36 | MP0000465_gastrointestinal_hemorrhage | 1.49790264 |
37 | MP0000371_diluted_coat_color | 1.45314244 |
38 | MP0003656_abnormal_erythrocyte_physiolo | 1.39991279 |
39 | MP0010678_abnormal_skin_adnexa | 1.38223010 |
40 | MP0004510_myositis | 1.36141804 |
41 | MP0001851_eye_inflammation | 1.35984763 |
42 | MP0004036_abnormal_muscle_relaxation | 1.35013761 |
43 | MP0005408_hypopigmentation | 1.34921483 |
44 | MP0003690_abnormal_glial_cell | 1.31946099 |
45 | MP0008877_abnormal_DNA_methylation | 1.31332131 |
46 | MP0000372_irregular_coat_pigmentation | 1.23626877 |
47 | MP0005000_abnormal_immune_tolerance | 1.21099201 |
48 | MP0004859_abnormal_synaptic_plasticity | 1.19170651 |
49 | MP0003121_genomic_imprinting | 1.18936201 |
50 | MP0005220_abnormal_exocrine_pancreas | 1.17747822 |
51 | MP0001177_atelectasis | 1.17350258 |
52 | MP0002723_abnormal_immune_serum | 1.17329093 |
53 | MP0000733_abnormal_muscle_development | 1.16832763 |
54 | MP0005275_abnormal_skin_tensile | 1.16821997 |
55 | MP0002075_abnormal_coat/hair_pigmentati | 1.16508202 |
56 | MP0009115_abnormal_fat_cell | 1.15658073 |
57 | MP0002420_abnormal_adaptive_immunity | 1.13343710 |
58 | MP0003868_abnormal_feces_composition | 1.10952908 |
59 | MP0001819_abnormal_immune_cell | 1.10291171 |
60 | MP0002168_other_aberrant_phenotype | 1.09965291 |
61 | MP0002398_abnormal_bone_marrow | 1.09511514 |
62 | MP0010386_abnormal_urinary_bladder | 1.08378872 |
63 | MP0000427_abnormal_hair_cycle | 1.06097501 |
64 | MP0000685_abnormal_immune_system | 1.06037887 |
65 | MP0001186_pigmentation_phenotype | 1.05933224 |
66 | MP0003566_abnormal_cell_adhesion | 1.05880750 |
67 | MP0003632_abnormal_nervous_system | 1.04519309 |
68 | MP0001545_abnormal_hematopoietic_system | 1.03903393 |
69 | MP0005397_hematopoietic_system_phenotyp | 1.03903393 |
70 | MP0005167_abnormal_blood-brain_barrier | 1.03610610 |
71 | MP0001879_abnormal_lymphatic_vessel | 1.02600847 |
72 | MP0001915_intracranial_hemorrhage | 1.02035197 |
73 | MP0000003_abnormal_adipose_tissue | 1.01352239 |
74 | MP0002090_abnormal_vision | 0.99812824 |
75 | MP0004233_abnormal_muscle_weight | 0.99597977 |
76 | MP0001661_extended_life_span | 0.98820018 |
77 | MP0009697_abnormal_copulation | 0.98784712 |
78 | MP0005171_absent_coat_pigmentation | 0.98050206 |
79 | MP0002909_abnormal_adrenal_gland | 0.95041322 |
80 | MP0001873_stomach_inflammation | 0.94588463 |
81 | MP0002088_abnormal_embryonic_growth/wei | 0.94401600 |
82 | MP0004883_abnormal_blood_vessel | 0.94209011 |
83 | MP0003984_embryonic_growth_retardation | 0.93341576 |
84 | MP0000604_amyloidosis | 0.92563700 |
85 | MP0000716_abnormal_immune_system | 0.92167320 |
86 | MP0003890_abnormal_embryonic-extraembry | 0.91734970 |
87 | MP0009703_decreased_birth_body | 0.91695770 |
88 | MP0004084_abnormal_cardiac_muscle | 0.90403199 |
89 | MP0002998_abnormal_bone_remodeling | 0.89771932 |
90 | MP0008569_lethality_at_weaning | 0.88011376 |
91 | MP0005621_abnormal_cell_physiology | 0.87666835 |
92 | MP0000689_abnormal_spleen_morphology | 0.87290088 |
93 | MP0003828_pulmonary_edema | 0.86743584 |
94 | MP0001299_abnormal_eye_distance/ | 0.86092005 |
95 | MP0004197_abnormal_fetal_growth/weight/ | 0.85754606 |
96 | MP0000703_abnormal_thymus_morphology | 0.85662632 |
97 | MP0000383_abnormal_hair_follicle | 0.83489168 |
98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82398598 |
99 | MP0002086_abnormal_extraembryonic_tissu | 0.80013303 |
100 | MP0003191_abnormal_cellular_cholesterol | 0.79872561 |
101 | MP0005671_abnormal_response_to | 0.79784117 |
102 | MP0004381_abnormal_hair_follicle | 0.79623971 |
103 | MP0003453_abnormal_keratinocyte_physiol | 0.78749086 |
104 | MP0003252_abnormal_bile_duct | 0.78348958 |
105 | MP0002133_abnormal_respiratory_system | 0.77767039 |
106 | MP0005388_respiratory_system_phenotype | 0.77767039 |
107 | MP0002419_abnormal_innate_immunity | 0.75240209 |
108 | MP0002136_abnormal_kidney_physiology | 0.75132888 |
109 | MP0003941_abnormal_skin_development | 0.74403433 |
110 | MP0004130_abnormal_muscle_cell | 0.74341663 |
111 | MP0006054_spinal_hemorrhage | 0.73821073 |
112 | MP0003763_abnormal_thymus_physiology | 0.73645139 |
113 | MP0000920_abnormal_myelination | 0.73086131 |
114 | MP0000537_abnormal_urethra_morphology | 0.72126042 |
115 | MP0004185_abnormal_adipocyte_glucose | 0.70973410 |
116 | MP0002396_abnormal_hematopoietic_system | 0.69627098 |
117 | MP0001672_abnormal_embryogenesis/_devel | 0.69480962 |
118 | MP0005380_embryogenesis_phenotype | 0.69480962 |
119 | MP0005384_cellular_phenotype | 0.69331540 |
120 | MP0004947_skin_inflammation | 0.68014894 |
121 | MP0008004_abnormal_stomach_pH | 0.67931984 |
122 | MP0004264_abnormal_extraembryonic_tissu | 0.67925736 |
123 | MP0005395_other_phenotype | 0.67418103 |
124 | MP0005310_abnormal_salivary_gland | 0.67354784 |
125 | MP0003631_nervous_system_phenotype | 0.66257717 |
126 | MP0004808_abnormal_hematopoietic_stem | 0.65655211 |
127 | MP0004134_abnormal_chest_morphology | 0.65298338 |
128 | MP0002722_abnormal_immune_system | 0.64908526 |
129 | MP0005375_adipose_tissue_phenotype | 0.64086996 |
130 | MP0003436_decreased_susceptibility_to | 0.63227966 |
131 | MP0004885_abnormal_endolymph | 0.63163847 |
132 | MP0005666_abnormal_adipose_tissue | 0.62923979 |
133 | MP0001958_emphysema | 0.60755451 |
134 | MP0000350_abnormal_cell_proliferation | 0.60690986 |
135 | MP0000377_abnormal_hair_follicle | 0.60417732 |
136 | MP0002095_abnormal_skin_pigmentation | 0.60343703 |
137 | MP0004742_abnormal_vestibular_system | 0.59793380 |
138 | MP0001784_abnormal_fluid_regulation | 0.59649031 |
139 | MP0001191_abnormal_skin_condition | 0.58663703 |
140 | MP0002429_abnormal_blood_cell | 0.58395809 |
141 | MP0003633_abnormal_nervous_system | 0.58304940 |
142 | MP0010630_abnormal_cardiac_muscle | 0.57552258 |
143 | MP0000428_abnormal_craniofacial_morphol | 0.57529679 |
144 | MP0005248_abnormal_Harderian_gland | 0.56957449 |
145 | MP0002925_abnormal_cardiovascular_devel | 0.56718062 |
146 | MP0005464_abnormal_platelet_physiology | 0.56666003 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of the fingertips (HP:0001211) | 3.70964232 |
2 | Macroorchidism (HP:0000053) | 3.46346400 |
3 | Dysmetric saccades (HP:0000641) | 3.45130985 |
4 | Hematochezia (HP:0002573) | 3.45004895 |
5 | Absent frontal sinuses (HP:0002688) | 3.35385698 |
6 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.35280799 |
7 | Volvulus (HP:0002580) | 3.18193485 |
8 | Acute myeloid leukemia (HP:0004808) | 3.11378888 |
9 | Thyroiditis (HP:0100646) | 3.02075261 |
10 | Thyroid carcinoma (HP:0002890) | 2.95024002 |
11 | Aqueductal stenosis (HP:0002410) | 2.88534576 |
12 | Overgrowth (HP:0001548) | 2.86311621 |
13 | Resting tremor (HP:0002322) | 2.78193807 |
14 | Colitis (HP:0002583) | 2.70309661 |
15 | Abnormality of the axillary hair (HP:0100134) | 2.69244367 |
16 | Abnormality of secondary sexual hair (HP:0009888) | 2.69244367 |
17 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.61258310 |
18 | Abnormality of the nasal septum (HP:0000419) | 2.58270236 |
19 | Generalized hypopigmentation of hair (HP:0011358) | 2.57861400 |
20 | Heterotopia (HP:0002282) | 2.55777564 |
21 | Scanning speech (HP:0002168) | 2.52620249 |
22 | Blue irides (HP:0000635) | 2.52516048 |
23 | Curly hair (HP:0002212) | 2.52457421 |
24 | Small epiphyses (HP:0010585) | 2.50961926 |
25 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.47774414 |
26 | Narrow palate (HP:0000189) | 2.47675401 |
27 | Fair hair (HP:0002286) | 2.45453347 |
28 | Bladder carcinoma (HP:0002862) | 2.44719687 |
29 | Bladder neoplasm (HP:0009725) | 2.44719687 |
30 | Spontaneous hematomas (HP:0007420) | 2.35807891 |
31 | Deep philtrum (HP:0002002) | 2.31102096 |
32 | Relative macrocephaly (HP:0004482) | 2.30235423 |
33 | Rhabdomyosarcoma (HP:0002859) | 2.27449316 |
34 | Medulloblastoma (HP:0002885) | 2.26498796 |
35 | Subacute progressive viral hepatitis (HP:0006572) | 2.25101189 |
36 | Excessive salivation (HP:0003781) | 2.22494343 |
37 | Drooling (HP:0002307) | 2.22494343 |
38 | Vertebral arch anomaly (HP:0008438) | 2.21924296 |
39 | Conjunctival telangiectasia (HP:0000524) | 2.21736879 |
40 | Cerebral aneurysm (HP:0004944) | 2.19804674 |
41 | Arterial tortuosity (HP:0005116) | 2.18639462 |
42 | Hyperventilation (HP:0002883) | 2.18517772 |
43 | Aortic aneurysm (HP:0004942) | 2.18003898 |
44 | Termporal pattern (HP:0011008) | 2.17506702 |
45 | Insidious onset (HP:0003587) | 2.17506702 |
46 | Truncal obesity (HP:0001956) | 2.16921657 |
47 | Hypopigmentation of the fundus (HP:0007894) | 2.16654561 |
48 | Papillary thyroid carcinoma (HP:0002895) | 2.15584160 |
49 | Febrile seizures (HP:0002373) | 2.15357941 |
50 | Myocardial infarction (HP:0001658) | 2.14808081 |
51 | Increased CSF protein (HP:0002922) | 2.12360631 |
52 | Recurrent viral infections (HP:0004429) | 2.11427825 |
53 | B lymphocytopenia (HP:0010976) | 2.10585055 |
54 | Abnormality of B cell number (HP:0010975) | 2.10585055 |
55 | Neonatal hypoglycemia (HP:0001998) | 2.09581200 |
56 | Hypochromic microcytic anemia (HP:0004840) | 2.07500107 |
57 | Postural instability (HP:0002172) | 2.06340629 |
58 | Osteolytic defects of the hand bones (HP:0009699) | 2.06143736 |
59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06143736 |
60 | Short chin (HP:0000331) | 2.05854610 |
61 | Limited elbow extension (HP:0001377) | 2.04435453 |
62 | Agammaglobulinemia (HP:0004432) | 2.03154700 |
63 | Chronic diarrhea (HP:0002028) | 2.03073259 |
64 | Germ cell neoplasia (HP:0100728) | 2.02393279 |
65 | Cubitus valgus (HP:0002967) | 2.01923023 |
66 | Gaze-evoked nystagmus (HP:0000640) | 2.01621099 |
67 | Biliary tract neoplasm (HP:0100574) | 2.01131092 |
68 | Protruding tongue (HP:0010808) | 1.99359585 |
69 | Abnormality of the periventricular white matter (HP:0002518) | 1.99137218 |
70 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.98788882 |
71 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.98370907 |
72 | Hypoplasia of the thymus (HP:0000778) | 1.98265489 |
73 | Submucous cleft hard palate (HP:0000176) | 1.98023181 |
74 | Hypoplastic ischia (HP:0003175) | 1.97954033 |
75 | Large earlobe (HP:0009748) | 1.97007894 |
76 | Inflammation of the large intestine (HP:0002037) | 1.96877048 |
77 | Lower limb amyotrophy (HP:0007210) | 1.94948877 |
78 | Widely spaced teeth (HP:0000687) | 1.94924591 |
79 | Flat acetabular roof (HP:0003180) | 1.94149859 |
80 | Spinal muscular atrophy (HP:0007269) | 1.93442808 |
81 | Verrucae (HP:0200043) | 1.92893274 |
82 | Papilloma (HP:0012740) | 1.92893274 |
83 | Recurrent bacterial skin infections (HP:0005406) | 1.92686159 |
84 | Gastrointestinal stroma tumor (HP:0100723) | 1.90821388 |
85 | Sparse lateral eyebrow (HP:0005338) | 1.89239862 |
86 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.87849300 |
87 | Periodontitis (HP:0000704) | 1.87831791 |
88 | Low anterior hairline (HP:0000294) | 1.85721649 |
89 | Neoplasm of striated muscle (HP:0009728) | 1.84284837 |
90 | Syringomyelia (HP:0003396) | 1.84086020 |
91 | Spinal cord lesions (HP:0100561) | 1.84086020 |
92 | Hypoplastic labia majora (HP:0000059) | 1.83534488 |
93 | Mitral valve prolapse (HP:0001634) | 1.82843410 |
94 | Viral hepatitis (HP:0006562) | 1.82448636 |
95 | Mediastinal lymphadenopathy (HP:0100721) | 1.82087740 |
96 | Vascular tortuosity (HP:0004948) | 1.81860652 |
97 | Persistence of primary teeth (HP:0006335) | 1.81684357 |
98 | Tapered finger (HP:0001182) | 1.81334724 |
99 | Abnormality of salivation (HP:0100755) | 1.81324322 |
100 | Abnormality of the frontal sinuses (HP:0002687) | 1.80960372 |
101 | Neoplasm of the heart (HP:0100544) | 1.80922883 |
102 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.80846946 |
103 | Coarse hair (HP:0002208) | 1.80750088 |
104 | Sandal gap (HP:0001852) | 1.79804235 |
105 | Abnormality of the right ventricle (HP:0001707) | 1.79425139 |
106 | Ulnar bowing (HP:0003031) | 1.78887976 |
107 | Anal stenosis (HP:0002025) | 1.78829209 |
108 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.77608965 |
109 | Lip pit (HP:0100267) | 1.77384656 |
110 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.77247153 |
111 | Mitral stenosis (HP:0001718) | 1.77244621 |
112 | Distal lower limb amyotrophy (HP:0008944) | 1.76323764 |
113 | Inappropriate behavior (HP:0000719) | 1.76098223 |
114 | Oligodactyly (hands) (HP:0001180) | 1.75025181 |
115 | Esophageal varix (HP:0002040) | 1.74575743 |
116 | Urinary urgency (HP:0000012) | 1.74235804 |
117 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.73606642 |
118 | Cystic hygroma (HP:0000476) | 1.72538338 |
119 | Urethral obstruction (HP:0000796) | 1.72503773 |
120 | Neoplasm of the adrenal cortex (HP:0100641) | 1.71919540 |
121 | Impaired vibratory sensation (HP:0002495) | 1.71289339 |
122 | Abnormality of the ischium (HP:0003174) | 1.71181147 |
123 | Slow saccadic eye movements (HP:0000514) | 1.70946835 |
124 | Chronic hepatic failure (HP:0100626) | 1.70154355 |
125 | IgA deficiency (HP:0002720) | 1.68257205 |
126 | Gastrointestinal inflammation (HP:0004386) | 1.67990604 |
127 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.67886155 |
128 | Gastrointestinal carcinoma (HP:0002672) | 1.67886155 |
129 | Uterine leiomyosarcoma (HP:0002891) | 1.67734995 |
130 | Leiomyosarcoma (HP:0100243) | 1.67734995 |
131 | T lymphocytopenia (HP:0005403) | 1.67124049 |
132 | Hypoplasia of the iris (HP:0007676) | 1.66936225 |
133 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.66324093 |
134 | Thick eyebrow (HP:0000574) | 1.66116335 |
135 | Pheochromocytoma (HP:0002666) | 1.65422484 |
136 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.65232827 |
137 | Prominent nose (HP:0000448) | 1.64678793 |
138 | Thoracolumbar scoliosis (HP:0002944) | 1.63955734 |
139 | Astrocytoma (HP:0009592) | 1.63785990 |
140 | Abnormality of the astrocytes (HP:0100707) | 1.63785990 |
141 | Gingivitis (HP:0000230) | 1.63566643 |
142 | Global brain atrophy (HP:0002283) | 1.62749470 |
143 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.62126094 |
144 | Arterial thrombosis (HP:0004420) | 1.61139828 |
145 | Genetic anticipation (HP:0003743) | 1.60622074 |
146 | Pulmonic stenosis (HP:0001642) | 1.60330427 |
147 | Long eyelashes (HP:0000527) | 1.59850967 |
148 | Disinhibition (HP:0000734) | 1.58585017 |
149 | Lower limb muscle weakness (HP:0007340) | 1.58509739 |
150 | Recurrent fungal infections (HP:0002841) | 1.58274617 |
151 | Abnormality of the labia majora (HP:0012881) | 1.56906500 |
152 | Abnormality of T cell number (HP:0011839) | 1.56332229 |
153 | Lower limb hyperreflexia (HP:0002395) | 1.55753015 |
154 | Osteomyelitis (HP:0002754) | 1.55103753 |
155 | Eczematoid dermatitis (HP:0000976) | 1.52943998 |
156 | Hemangiomatosis (HP:0007461) | 1.52900391 |
157 | Cellulitis (HP:0100658) | 1.52746153 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 3.49883003 |
2 | CDK12 | 3.44166731 |
3 | GRK6 | 3.22725061 |
4 | EEF2K | 2.58985466 |
5 | CAMK1D | 2.52852187 |
6 | SCYL2 | 2.41025005 |
7 | CAMK1G | 2.40324822 |
8 | RIPK4 | 2.26636237 |
9 | BRD4 | 2.24591527 |
10 | ACVR1B | 2.22305837 |
11 | MAP3K13 | 2.08779833 |
12 | FGFR2 | 2.03923204 |
13 | NEK9 | 1.88006315 |
14 | FGFR3 | 1.82129311 |
15 | LATS1 | 1.78957922 |
16 | PDGFRB | 1.74734978 |
17 | BMPR2 | 1.72940050 |
18 | WNK1 | 1.71793649 |
19 | SGK2 | 1.62900759 |
20 | SGK3 | 1.57215362 |
21 | MAP3K14 | 1.56523357 |
22 | PIK3CG | 1.55932152 |
23 | PKN2 | 1.53332071 |
24 | BLK | 1.51914156 |
25 | TRPM7 | 1.50660325 |
26 | JAK1 | 1.49681181 |
27 | NLK | 1.34543325 |
28 | MAP3K2 | 1.33680234 |
29 | INSRR | 1.31508987 |
30 | MELK | 1.31440638 |
31 | PDGFRA | 1.31302391 |
32 | SIK2 | 1.30771155 |
33 | EIF2AK3 | 1.29056787 |
34 | TTN | 1.27458547 |
35 | CDK9 | 1.26892173 |
36 | CHUK | 1.20840944 |
37 | MST4 | 1.19738677 |
38 | FER | 1.16887870 |
39 | PRPF4B | 1.12964703 |
40 | MAP3K7 | 1.09482106 |
41 | SIK1 | 1.09436893 |
42 | HCK | 1.08492491 |
43 | NUAK1 | 1.08117742 |
44 | MAPK7 | 1.06175834 |
45 | SGK223 | 1.00940428 |
46 | SGK494 | 1.00940428 |
47 | SGK1 | 0.97653224 |
48 | PTK6 | 0.97612144 |
49 | JAK2 | 0.96995719 |
50 | IKBKB | 0.96760923 |
51 | MAP3K4 | 0.95440876 |
52 | NTRK3 | 0.95085831 |
53 | STK10 | 0.94865809 |
54 | PIM1 | 0.94423116 |
55 | CSF1R | 0.93298853 |
56 | ZAK | 0.90682202 |
57 | MAP4K1 | 0.90180181 |
58 | STK39 | 0.89778037 |
59 | CDK6 | 0.89571709 |
60 | TYK2 | 0.89461727 |
61 | IRAK3 | 0.89442280 |
62 | MTOR | 0.89312778 |
63 | EPHA3 | 0.88966942 |
64 | LMTK2 | 0.88747149 |
65 | ERBB2 | 0.86964231 |
66 | LRRK2 | 0.86569441 |
67 | MAP3K10 | 0.85353229 |
68 | TGFBR2 | 0.82270244 |
69 | BTK | 0.81712299 |
70 | ITK | 0.81554336 |
71 | YES1 | 0.78475448 |
72 | GSK3A | 0.78352727 |
73 | CAMKK2 | 0.77482023 |
74 | TAOK3 | 0.76780140 |
75 | CSNK1A1L | 0.75088032 |
76 | CCNB1 | 0.74935134 |
77 | OBSCN | 0.74537355 |
78 | PRKCQ | 0.74056339 |
79 | CSK | 0.73746770 |
80 | PKN1 | 0.73515527 |
81 | PDK1 | 0.72619866 |
82 | STK38L | 0.72353834 |
83 | INSR | 0.70236892 |
84 | PRKAA2 | 0.70027196 |
85 | RIPK1 | 0.69360292 |
86 | KSR2 | 0.68519425 |
87 | MAPK10 | 0.67355872 |
88 | HIPK2 | 0.66629917 |
89 | IRAK1 | 0.65883160 |
90 | STK3 | 0.65476646 |
91 | CSNK1D | 0.65162227 |
92 | TRIB3 | 0.64763527 |
93 | PRKDC | 0.64201107 |
94 | FES | 0.64030328 |
95 | TEC | 0.62176804 |
96 | CSNK1G2 | 0.61651956 |
97 | CAMK4 | 0.60660886 |
98 | CDC42BPA | 0.60289872 |
99 | AKT3 | 0.60090098 |
100 | RPS6KB1 | 0.59770464 |
101 | STK24 | 0.59089600 |
102 | EGFR | 0.58463791 |
103 | BRSK2 | 0.57793951 |
104 | EPHB1 | 0.57414244 |
105 | RPS6KB2 | 0.56243647 |
106 | IRAK2 | 0.55360618 |
107 | GRK1 | 0.54860678 |
108 | TNIK | 0.54784026 |
109 | MARK2 | 0.54585805 |
110 | FGFR4 | 0.54404114 |
111 | STK11 | 0.53961466 |
112 | RPS6KA3 | 0.53518756 |
113 | ERBB3 | 0.52809774 |
114 | ATM | 0.51818198 |
115 | MAP3K9 | 0.51510348 |
116 | ROCK2 | 0.50900175 |
117 | ALK | 0.50852420 |
118 | MAP3K6 | 0.50674683 |
119 | BMPR1B | 0.49739613 |
120 | SYK | 0.49608944 |
121 | PDPK1 | 0.49517161 |
122 | PDK2 | 0.49141379 |
123 | MAPK11 | 0.48406751 |
124 | DMPK | 0.47502659 |
125 | MAPK12 | 0.47425650 |
126 | ATR | 0.46822233 |
127 | RAF1 | 0.46291988 |
128 | OXSR1 | 0.46061374 |
129 | JAK3 | 0.45980300 |
130 | PNCK | 0.45626390 |
131 | PIK3CA | 0.45468365 |
132 | TNK2 | 0.44933014 |
133 | MAPK8 | 0.44856661 |
134 | PRKAA1 | 0.44844011 |
135 | IKBKE | 0.44411452 |
136 | MAPK14 | 0.44132845 |
137 | FYN | 0.43882014 |
138 | ICK | 0.43349926 |
139 | RET | 0.43256344 |
140 | NEK6 | 0.42517909 |
141 | PRKCH | 0.42014744 |
142 | CHEK1 | 0.41143526 |
143 | CDK4 | 0.39170254 |
144 | MAPK1 | 0.34116140 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.55927569 |
2 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.23123275 |
3 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.86997398 |
4 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.83772708 |
5 | Lysine degradation_Homo sapiens_hsa00310 | 1.65427990 |
6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.55186846 |
7 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49011455 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43278059 |
9 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.37999904 |
10 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.37661485 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35361061 |
12 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.34927966 |
13 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.31075051 |
14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28536630 |
15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.27490992 |
16 | Insulin resistance_Homo sapiens_hsa04931 | 1.20224656 |
17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.18023917 |
18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15084466 |
19 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14113622 |
20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12781231 |
21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12236024 |
22 | Glioma_Homo sapiens_hsa05214 | 1.12135013 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.10334157 |
24 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.09710053 |
25 | Thyroid cancer_Homo sapiens_hsa05216 | 1.07507199 |
26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06781511 |
27 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04283291 |
28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03739401 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03508236 |
30 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02980428 |
31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02321009 |
32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01189874 |
33 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01138954 |
34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00095667 |
35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99165330 |
36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99059418 |
37 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98936499 |
38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98021234 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95530070 |
40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.95416745 |
41 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95382609 |
42 | Adherens junction_Homo sapiens_hsa04520 | 0.94824553 |
43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94619917 |
44 | Morphine addiction_Homo sapiens_hsa05032 | 0.94565541 |
45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94550570 |
46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94323914 |
47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93184538 |
48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90593912 |
49 | Prostate cancer_Homo sapiens_hsa05215 | 0.88988456 |
50 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88844618 |
51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88052265 |
52 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87805635 |
53 | Salivary secretion_Homo sapiens_hsa04970 | 0.87286870 |
54 | Long-term depression_Homo sapiens_hsa04730 | 0.86743685 |
55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86466728 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86448216 |
57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85068206 |
58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84614811 |
59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82885170 |
60 | Hepatitis B_Homo sapiens_hsa05161 | 0.82726274 |
61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81121439 |
62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80500483 |
63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79671892 |
64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79371796 |
65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79336116 |
66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79004282 |
67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77634837 |
68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.76958422 |
69 | Tuberculosis_Homo sapiens_hsa05152 | 0.76694016 |
70 | Platelet activation_Homo sapiens_hsa04611 | 0.76627447 |
71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75492495 |
72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75226975 |
73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75049312 |
74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74132561 |
75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74125817 |
76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73823241 |
77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73392103 |
78 | Lysosome_Homo sapiens_hsa04142 | 0.73229655 |
79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72539538 |
80 | Insulin secretion_Homo sapiens_hsa04911 | 0.72132762 |
81 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72005247 |
82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71696440 |
83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.71690829 |
84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71507628 |
85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71443822 |
86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70564587 |
87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70306143 |
88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70025005 |
89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69819658 |
90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69309484 |
91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68893589 |
92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68650365 |
93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68179214 |
94 | Focal adhesion_Homo sapiens_hsa04510 | 0.67992206 |
95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67935275 |
96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67669150 |
97 | Influenza A_Homo sapiens_hsa05164 | 0.67261052 |
98 | Alcoholism_Homo sapiens_hsa05034 | 0.66344469 |
99 | Hepatitis C_Homo sapiens_hsa05160 | 0.65983979 |
100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65867827 |
101 | Amoebiasis_Homo sapiens_hsa05146 | 0.64194012 |
102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64032613 |
103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64014308 |
104 | Measles_Homo sapiens_hsa05162 | 0.63267132 |
105 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62940236 |
106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62697206 |
107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.62138743 |
108 | Endocytosis_Homo sapiens_hsa04144 | 0.61972278 |
109 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61608035 |
110 | Axon guidance_Homo sapiens_hsa04360 | 0.61551266 |
111 | Asthma_Homo sapiens_hsa05310 | 0.61402073 |
112 | ABC transporters_Homo sapiens_hsa02010 | 0.61217201 |
113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61073778 |
114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60056084 |
115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58675045 |
116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57974617 |
117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57514122 |
118 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57003956 |
119 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56756035 |
120 | Melanoma_Homo sapiens_hsa05218 | 0.56662843 |
121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55970653 |
122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55095498 |
123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54661583 |
124 | Gap junction_Homo sapiens_hsa04540 | 0.53667730 |
125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50952637 |
126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50804790 |
127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50687548 |
128 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46027481 |